RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @…
Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @CritCareSociety @geetamehta0 #CriticalCare https://t.co/vbkAa2D0t4
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #CJA @CritCareSociety @geetamehta0 #CriticalCare #ICUtwitter https://t.co/4s9oGFx0am
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @C…
Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU @CritCareSociety @geetamehta0 #CriticalCare #ICUtwitter https://t.co/JcWqT8AfFD
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
RT @CJA_Journal: Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #C…
Outcomes of hematopoietic cell transplant recipients requiring invasive mechanical ventilation https://t.co/2AKjkPnwEU #CJA #CJA2019 @CritCareSociety @geetamehta0 #CriticalCare #ICUtwitter https://t.co/D7viMBXoVi
RT @StephenLap: Mechanical Ventilation in the bone marrow transplant recipient - 90-day mortality 73% by @geetamehta0 @BrunoFerreyro @Bram_…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @StephenLap: Mechanical Ventilation in the bone marrow transplant recipient - 90-day mortality 73% by @geetamehta0 @BrunoFerreyro @Bram_…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @StephenLap: Mechanical Ventilation in the bone marrow transplant recipient - 90-day mortality 73% by @geetamehta0 @BrunoFerreyro @Bram_…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @StephenLap: Mechanical Ventilation in the bone marrow transplant recipient - 90-day mortality 73% by @geetamehta0 @BrunoFerreyro @Bram_…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
Mechanical Ventilation in the bone marrow transplant recipient - 90-day mortality 73% by @geetamehta0 @BrunoFerreyro @Bram_Rochwerg and others.
RT @Bram_Rochwerg: Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared…
Outcomes of HSCT recipients who require IMV. 90-day mortality 73% and 🔼 to 90% if IMV >21 days. May help inform shared decision-making re: use and continuation of life support in this population. https://t.co/fEfPeSjVj1 @CJA_Journal @BrunoFerreyro @fe